Table 2 Awareness, treatment and control of hypertension and dyslipidemia in Chinese adults by glycemic status

Prevalence

21.9 (21.3, 22.4)

37.1 (36.6, 37.7)

56.8 (55.4, 58.2)

66.3 (64.5, 68.1)^a

Awareness

28.4 (27.3, 29.6)

32.0 (31.2, 32.8)

37.6 (35.9, 39.3)

55.2 (52.9, 57.5)^a

Treatment

19.2(18.2, 20.2)

22.8 (22.1, 23.5)

27.5 (26.0, 29.0)

43.7 (41.5, 46.0)^a

Control

19.6 (17.5, 21.9)

15.7 (14.6, 17.0)

3.5 (2.6, 4.8)

4.7 (3.5, 6.2)

Prevalence

47.2 (46.5, 47.9)

51.5 (50.9, 52.1)

63.2 (61.8, 64.5)

70.0 (68.2, 71.7)^a

Awareness

5.4 (5.0, 5.8)

8.3 (7.9, 8.7)

12.8 (11.7, 13.9)

33.9 (31.8, 36.1)^a

Treatment

2.3 (2.0, 2.5)

3.7 (3.5, 4.0)

5.4 (4.6, 6.2)

18.9 (17.2, 20.7)^a

Control

20.1 (15.8, 25.2)

15.6 (13.1, 18.5)

9.5 (6.4, 13.8)

15.9 (12.3, 20.3)

Total cholesterol control

94.3 (90.8, 96.5)

91.3 (89.1, 93.1)

89.3 (84.4, 92.8)

94.1 (91.5, 96.0)

LDL-C control

94.7 (91.6, 96.7)

88.2 (85.9, 90.2)

77.9 (71.1, 83.5)

87.4 (83.7, 90.3)^b

HDL-C control

28.2 (23.3, 33.6)

29.3 (26.0, 32.9)

27.2 (21.4, 34.0)

26.8 (22.4, 31.8)

Triglycerides control

61.3 (55.6, 66.7)

53.9 (50.1, 57.6)

44.2 (37.1, 51.5)

50.2 (45.0, 55.4)